The Oncosearch | Oncotarget

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics Research Paper

Itaru Yamamoto, Katsuhiko Nosho, Shinichi Kanno, Hisayoshi Igarashi, Hiroyoshi Kurihara, Keisuke Ishigami, Kazuya Ishiguro, Kei Mitsuhashi, Reo Maruyama, Hideyuki Koide, Hiroyuki Okuda, Tadashi Hasegawa, Yasutaka Sukawa, Kenji Okita, Ichiro Takemasa, Hiroyuki Yamamoto, Yasuhisa Shinomura, Hiroshi Nakase

Published Jan 27, 2017 · Vol. 8, No. 11 · pp. 17810-17818

The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo Research Paper

Laurence Booth, Jane L. Roberts, Cindy Sander, John Lee, John M. Kirkwood, Andrew Poklepovic, Paul Dent

Published Jan 27, 2017 · Vol. 8, No. 10 · pp. 16367-16386

MicroRNAs in melanoma development and resistance to target therapy Review

Luigi Fattore, Susan Costantini, Debora Malpicci, Ciro Francesco Ruggiero, Paolo Antonio Ascierto, Carlo M. Croce, Rita Mancini, Gennaro Ciliberto

Published Jan 19, 2017 · Vol. 8, No. 13 · pp. 22262-22278

The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis Research Paper

Anastasia De Luca, Debora Carpanese, Maria Cristina Rapanotti, Tara Mayte Suarez Viguria, Maria Antonietta Forgione, Dante Rotili, Chiara Fulci, Egidio Iorio, Luigi Quintieri, Sergio Chimenti, Luca Bianchi, Antonio Rosato, Anna Maria Caccuri

Published Jan 17, 2017 · Vol. 8, No. 9 · pp. 15520-15538

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer Research Paper

Murilo Vieira Geraldo, Helder Imoto Nakaya, Edna Teruko Kimura

Published Dec 24, 2016 · Vol. 8, No. 6 · pp. 9597-9607

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry Research Paper

William Bruno, Claudia Martinuzzi, Virginia Andreotti, Lorenza Pastorino, Francesco Spagnolo, Bruna Dalmasso, Francesco Cabiddu, Marina Gualco, Alberto Ballestrero, Giovanna Bianchi-ScarrÃ, Paola Queirolo, Federica Grillo, Luca Mastracci, Paola Ghiorzo, on behalf of the Italian Melanoma Intergroup (IMI)

Published Dec 22, 2016 · Vol. 8, No. 5 · pp. 8069-8082

BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis Research Paper

Yang-Hua Fan, Min-Hua Ye, Lei Wu, Miao-Jing Wu, Shi-Gang Lu, Xin-Gen Zhu

Published Dec 21, 2016 · Vol. 8, No. 4 · pp. 6295-6303

A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis Research Paper

Zeming Liu, Wen Zeng, Tianwen Chen, Yawen Guo, Chao Zhang, Chunping Liu, Tao Huang

Published Dec 21, 2016 · Vol. 8, No. 4 · pp. 6222-6232

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing Research Paper

Florian Selt, Juliane Hohloch, Thomas Hielscher, Felix Sahm, David Capper, Andrey Korshunov, Diren Usta, Sebastian Brabetz, Johannes Ridinger, Jonas Ecker, Ina Oehme, Jan Gronych, Viktoria Marquardt, David Pauck, Heidi BÃ¤chli, Charles D. Stiles, Andreas von Deimling, Marc Remke, Martin U. Schuhmann, Stefan M. Pfister, Tilman Brummer, David T.W. Jones, Olaf Witt, Till Milde

Published Dec 17, 2016 · Vol. 8, No. 7 · pp. 11460-11479

Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells Research Paper

Qiaoling Song, Xiaoxiao Sun, Hui Guo, Qiang Yu

Published Dec 17, 2016 · Vol. 8, No. 3 · pp. 5003-5015

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer Research Paper

Eliza Vakana, Susan Pratt, Wayne Blosser, Michele Dowless, Nicholas Simpson, Xiu-Juan Yuan, Susan Jaken, Jason Manro, Jennifer Stephens, Youyan Zhang, Lysiane Huber, Sheng-Bin Peng, Louis F. Stancato

Published Dec 16, 2016 · Vol. 8, No. 6 · pp. 9251-9266

Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer Research Paper

Hassan Ashktorab, Pooneh Mokarram, Hamed Azimi, Hasti Olumi, Sudhir Varma, Michael L. Nickerson, Hassan Brim

Published Dec 16, 2016 · Vol. 8, No. 5 · pp. 7852-7866

A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration Research Paper

Manon Ouimet, Simon Drouin, Mathieu Lajoie, Maxime Caron, Pascal St-Onge, Romain Gioia, Chantal Richer, Daniel Sinnett

Published Dec 15, 2016 · Vol. 8, No. 5 · pp. 7477-7488

Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature Research Paper

Haleh Davanian, Anangi Balasiddaiah, Robert Heymann, Magnus SundstrÃ¶m, Poppy RedenstrÃ¶m, Mikael Silfverberg, David Brodin, Matti SÃ¤llberg, Sven Lindskog, Carina Kruger Weiner, Margaret Chen

Published Dec 10, 2016 · Vol. 8, No. 3 · pp. 4530-4542

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number Clinical Research Papers

Ewa Szutowicz-ZieliÅ„ska, Krzysztof Konopa, Anna Kowalczyk, MaÅ‚gorzata Suszko-KaÅ¼arnowicz, Renata Duchnowska, Aleksandra SzczÄ™sna, Magdalena Ratajska, Aleksander Sowa, Janusz Limon, Wojciech Biernat, Tomasz Burzykowski, Jacek Jassem, RafaÅ‚ Dziadziuszko

Published Dec 4, 2016 · Vol. 8, No. 10 · pp. 17270-17278

Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq Research Paper

Tobias Gerber, Edith Willscher, Henry Loeffler-Wirth, Lydia Hopp, Dirk Schadendorf, Manfred Schartl, Ulf Anderegg, Gray Camp, Barbara Treutlein, Hans Binder, Manfred Kunz

Published Nov 26, 2016 · Vol. 8, No. 1 · pp. 846-862

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation Research Paper

Hyung Kwon Byeon, Hwi Jung Na, Yeon Ju Yang, Sooah Ko, Sun Och Yoon, Minhee Ku, Jaemoon Yang, Jae Wook Kim, Myung Jin Ban, Ji-Hoon Kim, Da Hee Kim, Jung Min Kim, Eun Chang Choi, Chang-Hoon Kim, Joo-Heon Yoon, Yoon Woo Koh

Published Nov 21, 2016 · Vol. 8, No. 1 · pp. 596-609

Evolutionary biologic changes of gut microbiota in an â€˜adenoma-carcinoma sequenceâ€™ mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine Research Paper

Teng Sun, Shanglong Liu, Yanbing Zhou, Zengwu Yao, Dongfeng Zhang, Shougen Cao, Zhiliang Wei, Bin Tan, Yi Li, Zheng Lian, Song Wang

Published Nov 18, 2016 · Vol. 8, No. 1 · pp. 444-457

Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness Research Paper

Tao Zhang, Xiaopei Shen, Rengyun Liu, Guangwu Zhu, Justin Bishop, Mingzhao Xing

Published Nov 16, 2016 · Vol. 8, No. 1 · pp. 900-914

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF^V600 mutated malignancies Research Paper

Parisa Momtaz, Elena Pentsova, Omar Abdel-Wahab, Eli Diamond, David Hyman, T. Merghoub, Daoqi You, Billel Gasmi, Agnes Viale, Paul B. Chapman

Published Nov 16, 2016 · Vol. 7, No. 51 · pp. 85430-85436

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics Research Paper

The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo Research Paper

MicroRNAs in melanoma development and resistance to target therapy Review

The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis Research Paper

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer Research Paper

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry Research Paper

BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis Research Paper

A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis Research Paper

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing Research Paper

Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells Research Paper

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer Research Paper

Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer Research Paper

A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration Research Paper

Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature Research Paper

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number Clinical Research Papers

Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq Research Paper

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation Research Paper

Evolutionary biologic changes of gut microbiota in an â€˜adenoma-carcinoma sequenceâ€™ mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine Research Paper

Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness Research Paper

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF^V600 mutated malignancies Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics Research Paper

The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo Research Paper

MicroRNAs in melanoma development and resistance to target therapy Review

The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis Research Paper

Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer Research Paper

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry Research Paper

BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis Research Paper

A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis Research Paper

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing Research Paper

Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells Research Paper

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer Research Paper

Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer Research Paper

A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration Research Paper

Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature Research Paper

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number Clinical Research Papers

Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq Research Paper

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation Research Paper

Evolutionary biologic changes of gut microbiota in an â€˜adenoma-carcinoma sequenceâ€™ mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine Research Paper

Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness Research Paper

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies Research Paper

Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAF^V600 mutated malignancies Research Paper